Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

WHITE GLOBAL PHARMA CONSULTANTS LLC

UEI: G9DQBFF4BD17CAGE: 6QXM9

WHITE GLOBAL PHARMA CONSULTANTS LLC is a federal contractor, registered under UEI G9DQBFF4BD17 and CAGE code 6QXM9. It has been awarded $364,869 in federal contracts. Primary work spans All Other Professional, Scientific, and Technical Services and Other Scientific and Technical Consulting Services. Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

G9DQBFF4BD17

CAGE Code

6QXM9

Entity Structure

Sole Proprietorship

Established

N/A

Business Classifications

For Profit OrganizationLimited Liability Company

NAICS Codes

541690Other Scientific and Technical Consulting Services(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

WHITE GLOBAL PHARMA CONSULTANTS LLC specializes in providing expert consulting services in drug metabolism and pharmacokinetics (DMPK), supporting federal agencies in the evaluation of pharmaceutical compound behavior within biological systems. Their core capabilities center on preclinical and clini...

WHITE GLOBAL PHARMA CONSULTANTS LLC specializes in providing expert consulting services in drug metabolism and pharmacokinetics (DMPK), supporting federal agencies in the evaluation of pharmaceutical compound behavior within biological systems. Their core capabilities center on preclinical and clinical pharmacology advisory, including in vitro and in vivo ADME studies, bioanalytical method development, species selection for toxicology models, and data interpretation to inform regulatory submissions. The firm brings deep technical expertise in pharmacokinetic modeling, clearance mechanisms, drug-drug interaction prediction, and metabolic pathway analysis, enabling clients to de-risk drug development pipelines and optimize dosing strategies. Their differentiation lies in translating complex pharmacological data into actionable regulatory and development insights, particularly for early-stage drug candidates requiring precise pharmacokinetic profiling. The contractor has delivered services to the Department of Health and Human Services, focusing on scientific support for drug evaluation and development initiatives. Their engagement reflects a targeted, science-driven partnership where specialized pharmacological consulting is required to advance public health objectives, particularly in areas involving novel therapeutics and metabolic safety assessment. Their primary industry focus is under NAICS 541990, which encompasses specialized professional services in pharmaceutical science that fall outside standard clinical research or laboratory testing categories. This positions them as a niche provider of high-value, knowledge-intensive consulting in drug development, serving biopharmaceutical stakeholders within federal health programs. As a small business structured as 2J and based in Cranbury, New Jersey, WHITE GLOBAL PHARMA CONSULTANTS LLC operates with agility and deep subject matter expertise. While they hold no formal government certifications, their market positioning is anchored in scientific credibility and specialized technical delivery within the federal pharmaceutical support ecosystem.

Key Performance Metrics

Awards Count

3

All time

Active

0

Currently performing

Completed

3

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with WHITE GLOBAL PHARMA CONSULTANTS LLC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for WHITE GLOBAL PHARMA CONSULTANTS LLC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in WHITE GLOBAL PHARMA CONSULTANTS LLC's top NAICS codes and agencies

NAICS: 541990
New
SLED
Actuarial Services for the Stanley G. Tate Florida Prepaid College Program
Solicitation # ITN 26-02
The State Board of Administration is seeking a qualified firm to provide independent actuarial services for the Stanley G. Tate Florida Prepaid College Program. The primary objective is to ensure the actuarial soundness of the Prepaid Plan and to establish accurate plan pricing in accordance with the Actuarial Standards of Practice, the Actuarial Code of Professional Conduct, Section 529 of the Internal Revenue Code, and relevant Florida Statutes. The selected provider will be responsible for a wide range of core deliverables, including four quarterly actuarial valuation letters with monthly cash flow projections, one annual actuarial valuation report, and one annual plan pricing report for the designated enrollment period. Additional requirements include the development of a sensitivity matrix for material actuarial drivers, annual presentations to the Board, and the maintenance of a comprehensive continuity and data security plan. The procurement process, conducted under Section 287.057 of the Florida Statutes, utilizes a multi-phase competitive approach starting with a binary pass/fail assessment of mandatory requirements, followed by a detailed evaluation of organizational experience, scope of services, value-added offerings, and pricing. The resulting contract will include an initial term with the possibility of up to five one-year renewal periods. Beyond core valuations and pricing, the actuary may be called upon to provide additional services such as legislative analysis, fiscal note preparation, and specialized actuarial studies. All services must be supported by detailed work papers and quality control procedures to facilitate Board oversight and potential transition to a successor provider.
State Board of Administration

POSTED

1 day ago

DEADLINE

in 7 months
View Details